Justice Department Preparing Legal Action Against Live Nation

Entertainment

New information from sources in the Justice Department suggests that the US government is preparing legal action against Live Nation for violating the merger settlement Live Nation and Ticketmaster reached with the government in 2010.


The settlement, known as a consent decree, at its core, forbade Live Nation from forcing venues that want to book the concert promoter’s tours to use Ticketmaster for those shows, and from retaliating when venues choose to use a ticketing competitor instead. The fact that Ticketmaster now controls 80% of the market and tickets prices are up on average by 50% since 2009 — to $92.42 — for the top 100 tours worldwide caught the attention of Washington, D.C. representatives.

Assistant Attorney General Makan Delrahim, the Justice Department’s antitrust chief, confirmed during a September Senate hearing that the department was investigating allegations that Live Nation had been violating the decree.

Writes the Wall Street Journal,

In August, Sens. Richard Blumenthal (D., Conn.) and Amy Klobuchar (D., Minn.) asked DOJ to investigate the state of competition in ticketing, focusing on the Live Nation-Ticketmaster merger.

Last week, four House lawmakers sent a letter to the department that expressed concerns about the merger, saying, “Our constituents are facing significantly increased live event prices and a lack of meaningful alternatives to purchase tickets to live events.”

The signatories were Reps. Ken Buck (R., Colo.), Matt Gaetz (R., Fla.), Lucy McBath (D., Ga.) and James Sensenbrenner (R., Wis.).

Speaking at a conference in mid-September, Live Nation Chief Executive Michael Rapino was confident that his company had not engaged in any antitrust practices. “We have no fear that we have any systematic issues. We’re very compliant,” he said.

Though many companies have arisen in the past decade to challenge Ticketmaster, including the AEG-powered AXS, which was built upon Ticketmaster’s own IP (as part of the 2009 settlement), none have been able to establish themselves as serious competitors.

via WSJ

Products You May Like

Articles You May Like

NICE’s methodology means people with cancer aren’t getting drugs – AstraZeneca’s Sir Pascal Soriot said | Business News
The Safari Jacket: Most Practical Item in 2024
Security guard dead after shooting at Main Event; man detained
Meta debuts newest Llama AI model with help from Nvidia and others
Elon Musk’s transgender daughter, in first interview, says he berated her for being queer as a child